RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology.
RocketVax has raised €6.7M across 1 funding round from 3 investors, most recently a Series A round in Aug 2021. Based in Basel, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-05 | Series A | €6.7M |
| Canton of Basel-Stadt,Innosuisse,University Hospital Basel |
| View deal → |
